CareDx, Inc (CDNA) vs Regencell Bioscience Holdings Limited (RGC)
A side-by-side comparison of CareDx, Inc and Regencell Bioscience Holdings Limited across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CDNA
CareDx, Inc
$63.79HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
RGC
Regencell Bioscience Holdings Limited
$7.35HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — CDNA vs RGC
growth of $100 · dividends reinvested · last 5yCDNA -11.6% (-2.4%/yr)RGC +2520.2% (+92.2%/yr)RGC compounded faster over this window
Log scale — wide-divergence pair
CDNA RGC
CDNA vs RGC: by the numbers
- •RGC is the larger company ($3.64B vs $3.30B market cap).
- •CDNA is profitable (24.23% net margin) while RGC runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | CDNA | RGC |
|---|---|---|
| P/E ratio | 30.80 | N/A |
| Forward P/E | 53.26 | N/A |
| P/S ratio | 7.20 | N/A |
| P/B ratio | 7.75 | 2986.54 |
| EV / EBITDA | 189.34 | N/A |
| FCF yield | 2.58% | N/A |
Profitability
| Metric | CDNA | RGC |
|---|---|---|
| Gross margin | 70.58% | 0.00% |
| Operating margin | -0.92% | 0.00% |
| Net margin | 24.23% | 0.00% |
| ROE | 26.08% | -73.75% |
| ROIC | -0.93% | -69.75% |
Growth (annualized)
| Metric | CDNA | RGC |
|---|---|---|
| Revenue CAGR (5Y) | 12.56% | N/A |
| Total return CAGR (5Y) | 1.33% | 67.94% |
Frequently asked
- Is CDNA or RGC more profitable?
- CDNA runs the higher net margin — CDNA at 24.23% versus RGC at 0.00%.
- How have CDNA and RGC total returns compared?
- Over the past 5 years, CDNA delivered 1.33% and RGC delivered 67.94% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
CareDx P/E ratioCareDx ROERegencell Bioscience ROECareDx operating marginRegencell Bioscience operating marginCareDx revenue growthRegencell Bioscience revenue growthCareDx free cash flowRegencell Bioscience free cash flow
CareDx & Regencell Bioscience appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.